Clinical trials aimed at preventing hematoma expansion in patients with intraparenchymal hemorrhage have failed to show benefit from experimental intervention. Novel methods for identifying those patients at the highest risk of hemorrhage growth might enable better patient selection and, hence, increase the chance of demonstrating an improvement in clinical outcome.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dennis, M. S. Outcome after brain haemorrhage. Cerebrovasc. Dis. 16 (Suppl. 1), 9–13 (2003).
Brott, T. et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28, 1–5 (1997).
Mayer, S. A. et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N. Engl. J. Med. 358, 2127–2137 (2008).
Anderson, C. S. et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 7, 391–399 (2008).
Delgado Almandoz, J. E. et al. Systematic characterization of the computed tomography angiography spot sign in primary intracerebral hemorrhage identifies patients at highest risk for hematoma expansion. The spot sign score. Stroke doi:10.1161/STROKEAHA.109.554667.
Wada, R. et al. CT angiography “spot sign” predicts hematoma expansion in acute intracerebral hemorrhage. Stroke 38, 1257–1262 (2007).
Goldstein, J. N. et al. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology 68, 889–894 (2007).
Becker, K. J. et al. Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke 30, 2025–2032 (1999).
Stroke Trials Registry STOP-IT. The Spot Sign for Predicting and Treating ICH Growth Study [online], (2009).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
D. Tirschwell has received has received grant support from Novo Nordisk. K. Becker declares no competing interests.
Rights and permissions
About this article
Cite this article
Becker, K., Tirschwell, D. 'Spotting' patients at the highest risk of hematoma growth. Nat Rev Neurol 5, 526–528 (2009). https://doi.org/10.1038/nrneurol.2009.152
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2009.152
This article is cited by
-
Prevalence and diagnostic performance of computed tomography angiography spot sign for intracerebral hematoma expansion depend on scan timing
Neuroradiology (2014)
-
Extended analysis of the spot sign score's performance
Nature Reviews Neurology (2010)